United States · FDA National Drug Code directory

Claritin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
11523-4330_45370735-3f9c-a7f8-e063-6294a90aa0c6
Product NDC
11523-4330
Form
TABLET, CHEWABLE
Composition / generic term
loratadine
Labeler
Bayer HealthCare LLC.
Marketing category
NDA
Marketing start / end (source format)
20150925
Source listing expiry
20261231

Source-listed ingredients

  • LORATADINE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (11523-4330-1) / 10 TABLET, CHEWABLE in 1 BLISTER PACK · 11523-4330-1
  • 3 BLISTER PACK in 1 CARTON (11523-4330-3) / 10 TABLET, CHEWABLE in 1 BLISTER PACK · 11523-4330-3
  • 4 BLISTER PACK in 1 CARTON (11523-4330-4) / 10 TABLET, CHEWABLE in 1 BLISTER PACK · 11523-4330-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →